ILO Exchange

Your Details

1 Olympic licence(s) €2000

Your personal data will be used to process your order, support your experience throughout this website, and for other purposes described in our privacy policy.

I have read and agree to the buyer terms and conditions.
Buy ILO

11%

revenue
pot

ILO Price

€2000

Total

€2000

  Buy  

 

ilocx

Olympic Therapeutics AG

€2000

right__we

Olympic Therapeutics was formed by specialists to develop a new class of Antifungal Medications for the treatment of resistant Fungal Infections.

Fungal Diseases

Globally, over 300 million people are afflicted with a serious fungal infection and 25 milllion are at high risk of dying or losing their sight.

For years, we have been researching the treatment of complicated fungal diseases and have successfully started to develop appropriate drugs.

In order to bring our previous research results and the associated drugs to market, Olympic Therapeutics AG was founded by researchers and scientists.

GREENSHEET | The Numbers

6,000

ILO Units in Total Issue

 

 

€2000

Price

Olympic Therapeutics AG Revenues

Our projected revenues are as follows:

Royalty Pot

10th October 2018 onwards : 11%

3rd April 2020

Develop Contract Research Organization agreement for formal Preclinical Studies of Test Article Drug Substance OCT -101.

1st April 2020

Establish full cGMP Manufacturing Protocol and Methods.

2nd January 2020

Complete analysis of in vitro Pre-Clinical Safety and Efficacy Studies, and Validation of Analytical Methods for Release.

1st January 2020

Complete cGMP Manufacturing of cGMP Test Article and QA/QC Analytical Methods for Release.

2nd October 2019

Initiate in vitro Preclinical Efficacy Studies of OCT-101

Using Near cGMP Test Article Drug Substance OCT -101.

1st October 2019

Continue Facilities Development

.

3rd July 2019

Initiate Regulatory Document Development.

2nd July 2019

Initiate in vitro Preclinical Safety Studies of OCT-101

Using Near cGMP Test Article Drug Substance OCT -101.

2nd July 2019

Continue Facilities Development.

3rd April 2019

Manufacture Near cGMP

Test Article Drug Substance

2nd April 2019

Facilities Development

Execution of Contract Manufacturing Agreement for OCT-101.

10th October 2018

Financing by ILO resolved

Board of Directors decided to make an ILO to finance research and development.

28th June 2018

First Round Financing

First round financing completed by preferred shares.

11th January 2018

Company Foundation

The Company became the name Olympic Therapeutics AG.

THE TEAM

DOCUMENTS | Read more

CONTACT | Olympic Therapeutics AG

Olympic Therapeutics AG

Steinhausserstr. 74, CH-6300 Zug